The United States approves the drug “Paxolovid” from Pfizer to treat...

The United States of America has approved the emergency use of Pfizer’s pills, offering a more appropriate treatment option for at-risk patients at a critical stage of the pandemic.

The drug, called “Paxlovid”, is the first home remedy for Covid-19 to be approved by the US Food and Drug Administration.

The drug is expected to become a powerful weapon in the fight against the virus as production begins, giving people at risk of developing serious complications of the disease a way to avoid hospitalization.

“This license provides a new tool to combat Covid-19 at a critical time in the pandemic, with the emergence of new mutated strains,” Bloomberg News Agency quoted Patricia Cavazzoni, director of the Center for Drug Evaluation and Research at the US Food and Drug Administration, as saying.

The treatment is intended to treat cases of mild to moderate Covid-19 disease (COVID-19) among adults in the “threatened” category with severe disease progression, and even in children 12 years and older, or weighing at least 40 kg, with positive SARS test results. -CoV-2.

According to what was published US Food and Drug Administration website The drug is available by prescription only and should be started as soon as possible after COVID-19 is diagnosed and within five days of symptoms appearing.

Pfizer says its research has confirmed that the new drug reduces the risk of death from illness and the odds of hospitalization in a deteriorating condition by 89 percent. According to the preliminary statistical results of the study,.

“Having an oral pill is a huge step forward in the fight against this epidemic and promises to make antiviral treatment more accessible to patients at high risk of developing moderate to severe disease,” Cavazoni says.

The US Food and Drug Administration confirms that Baxlovid is not a substitute for vaccination.

Paxlovid consists of two drugs: the first is nirmatrelvir, which inhibits the SARS-CoV-2 protein, which prevents the virus from multiplying, and ritonavir, which slows down the process of breaking down the first drug to help it stay in the body for longer at higher concentrations.

Paxlovid is given as three tablets (two nirimatilvir tablets and one ritonavir tablet). They are taken together orally twice daily for five days, for a total of 30 tablets. Paxlovid is not allowed to be used for more than five consecutive days, as confirmed by the US Food and Drug Administration.

Emad Hassan

  • Joe Biden receives the Pfizer/Biontech vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Biontech/Pfizer Vaccine

    Developed by German Piontech jointly with American Pfizer. Its effectiveness, according to the latest clinical trials, is 95 percent. It is the first vaccine against corona authorized by the World Health Organization. It is based on mRNA technology, and is the most popular vaccine in the Western world, but it has been criticized for the difficulty of storing it, as it needs to minus 70 degrees Celsius to maintain its effectiveness.

  • لقاح موديرنا

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Moderna

    The second vaccine to be licensed by the European Union after Pfizer/Biontech. Developed by the American company Moderna in cooperation with the US National Institutes of Health for Infectious Diseases. Its effectiveness has reached 95 percent. It adopts almost the same technology (mRNA), but its storage conditions are less stringent and it needs 20 degrees below zero. Despite this, the quantities of its distribution in the world remained less than the first vaccine, which may be explained by its price of $ 33 per dose, unlike the second vaccine of $ 20.

  • Sabotonic fertilization V

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sputnik V

    It is the first vaccine in the world whose developers announce its effectiveness against Corona, even though it had not yet passed the third stage. It was developed by the Russian State Aesthetic Institute, and its effectiveness reaches 92 percent, according to Russian figures, but with Western scientific hesitation due to the lack of published data on it. It was imported by several countries, including Hungary, Algeria, Serbia and the UAE. It’s easy to transport and cheap ($10) and uses adenovirus (or adenovirus) vector technology.

  • AstraZeneca - vaccine manufacturer

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    AstraZeneca/Oxford

    The second vaccine authorized by the World Health Organization and the third for the European Union. The cheapest vaccines, but also the least effective (70 percent), and many countries questioned its effectiveness against the elderly, as well as against mutated versions. It was developed by the British-Swedish company AstraZeneca in cooperation with the University of Oxford. It was imported by several countries after the contribution of the Serum Institute of India to its production. It is easy to transport and store and it also uses glandular conveyor technology.

  • Fertilization of Sinofarm

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sinopharm

    Developed by China’s state-owned Sinopharm with Beijing Institute of Biological Products. It was first introduced by the UAE before China licensed it, and then it was imported by several countries, including Morocco, Jordan and Egypt. Its efficacy rate, according to its manufacturers, reached 79 percent, but the scientific data is not published properly. It uses the inactivated virus injection technique, and the biggest mystery surrounding it is its price, as several reports stated that the dose is not less than $ 30, while others mentioned a lower or higher price.

  • Recep Tayyip Erdogan receives a dose of Coronavac vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Coronavac

    It was produced by the Chinese company Sinovac, but licensing it in China took longer. Its effectiveness is controversial, as tests in Brazil showed that it did not exceed 51 percent, but other tests in Turkey, which was among the first to license it, raised the effectiveness to 91 percent. He uses the same technology as the Sinopharma vaccine, and many questions are hovering around him due to the lack of data, especially its price, which has not been reported, although reports have estimated it at ten dollars.

  • Johnson & Johnson Vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Johnson & Johnson

    It was developed by the American company “Johnson & Johnson”, and South Africa began using it, although it was not licensed in the United States or Europe, after it was found that it was able to confront the mutated version, contrary to what was shown by first experiments. Its effectiveness is estimated at 66 percent globally and 72 in America. It is distinguished from others that it is from a single dose, which strengthens its chances of spreading even more. It uses adenovirus vector technology, and is easy to store.

These were the details of the news The United States approves the drug “Paxolovid” from Pfizer to treat... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

Author Information

I have been an independent financial adviser for over 11 years in the city and in recent years turned my experience in finance and passion for journalism into a full time role. I perform analysis of Companies and publicize valuable information for shareholder community. Address: 2077 Sharon Lane Mishawaka, IN 46544, USA Phone: (+1) 574-255-1083 Email: [email protected]